From Ramesh Damani to Atul Suri; Dipan Mehta to Nilesh Shah; Dharmesh Kant to Deven Choksey, here's what these market experts ...

​This partnership builds on an earlier collaboration, which was launched between the two companies in 2022. As part of this ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 9, ...

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is one of the 11 Dirt Cheap Stocks to Buy According to Analysts. On October 3 ...

Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.

An investigational treatment, used in combination with another cancer medication, took an important step forward after ...

Christopher Gibson, Chief Executive Officer of Recursion Pharmaceuticals, recently sold a significant chunk of his company's common stock. The CEO of Recursion Pharmaceuticals recently disposed of 120 ...

Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...

The pharmaceutical company has also earned approval for Wegovy in treating metabolic dysfunction-associated steatohepatitis ...

Pfizer ( PFE) is number one and the leader in my list of "top 3 Big Pharma stocks." Over the last three quarters I have seen ...

CRMD, CELC, RANI, and RAPT are pushing aggressively to the upside on Monday. Here's what is driving these four biotech stocks ...